PSA
58
2
UPS
60
9
CMA
61
5
SIG
52
3
SWK
64
5
HON
67
2
VRSN
53
-4
SNA
68
-2
PNC
64
4
CHRW
56
-3
DOW
44
10
URBN
56
14
HRB
57
5
EFX
38
2
SYY
53
4
AN
58
4
SYK
64
-4
TGT
22
2
GOOG
50
-3
GPC
40
3
PSA
58
2
UPS
60
9
CMA
61
5
SIG
52
3
SWK
64
5
HON
67
2
VRSN
53
-4
SNA
68
-2
PNC
64
4
CHRW
56
-3
DOW
44
10
URBN
56
14
HRB
57
5
EFX
38
2
SYY
53
4
AN
58
4
SYK
64
-4
TGT
22
2
GOOG
50
-3
GPC
40
3
Financhill
Back

Autolus Therapeutics PLC 10K Form

Buy
53

AUTL
Autolus Therapeutics PLC

Last Price:
2.95
Seasonality Move:
-10.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AUTL News And Ratings

See the #1 stock for the next 7 days that we like better than AUTL

AUTL Financial Statistics

Sales & Book Value

Annual Sales: $1.7M
Cash Flow: $-86.33M
Price / Cash Flow: 0
Annual Sales: $1.79
Price / Book: 1.64

Profitability

EPS (TTM): -1.22000
Net Income (TTM): $-270.23M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Autolus Therapeutics PLC Earnings Forecast

Key Autolus Therapeutics PLC Financial Ratios

  • The Research & Development expenses have been 7,684.39% of Revenue.
  • The Interest Expense is -21.63% of Operating Income.
  • The Net Earning history of AUTL is -12,272.26% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 5 years.

Autolus Therapeutics PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: AUTL
CUSIP: 05280R
Website: autolus.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AUTL Technical Analysis vs Fundamental Analysis

Buy
53
Autolus Therapeutics PLC (AUTL) is a Buy

Is Autolus Therapeutics PLC a Buy or a Sell?